PTC Therapeutics (PTCT)
(Delayed Data from NSDQ)
$34.09 USD
+0.52 (1.55%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $34.07 -0.02 (-0.06%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth B Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/01/2024
Time: -- |
6/2024 | $-1.00 | -4.35% |
Earnings Summary
For their last quarter, PTC Therapeutics (PTCT) reported earnings of -$1.20 per share, beating the Zacks Consensus Estimate of $-1.21 per share. This reflects a positive earnings surprise of 0.83%. Look out for PTCT's next earnings release expected on August 01, 2024. For the next earning release, we expect the company to report earnings of -$1.00 per share, reflecting a year-over-year increase of 62.41%.
Earnings History
Price & Consensus
Zacks News for PTCT
Indivior PLC (INDV) Q2 Earnings and Revenues Beat Estimates
PTCT: What are Zacks experts saying now?
Zacks Private Portfolio Services